These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. Nishikawa K; Morii T; Ako H; Hamada K; Saito S; Narita N J Allergy Clin Immunol; 1992 Aug; 90(2):169-74. PubMed ID: 1500624 [TBL] [Abstract][Full Text] [Related]
3. Surface antigens on eosinophils in bronchial asthma and eosinophilic pneumonia. Sakamoto S; Oki K; Takahashi H; Arakawa Y; Sugita H; Kawabata Y; Takeuchi K; Tomichi N Int Arch Allergy Immunol; 1995; 108 Suppl 1():6-8. PubMed ID: 7549526 [TBL] [Abstract][Full Text] [Related]
4. The effect of transendothelial migration on eosinophil function. Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830 [TBL] [Abstract][Full Text] [Related]
5. Mature human eosinophils have the capacity to express HLA-DR. Lucey DR; Nicholson-Weller A; Weller PF Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1348-51. PubMed ID: 2919183 [TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Fujimura M; Yasui M; Shinagawa S; Nomura M; Matsuda T Respir Med; 1998 May; 92(5):743-9. PubMed ID: 9713634 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of HLA-DR expression on activated human blood eosinophils by transforming growth factor-beta1. Luttmann W; Franz P; Schmidt S; Barth J; Matthys H; Virchow JC Scand J Immunol; 1998 Dec; 48(6):667-71. PubMed ID: 9874502 [TBL] [Abstract][Full Text] [Related]
8. Adhesion molecule expression on eosinophils in idiopathic eosinophilic pneumonia. Azuma M; Nakamura Y; Sano T; Okano Y; Sone S Eur Respir J; 1996 Dec; 9(12):2494-500. PubMed ID: 8980959 [TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-related antigen on eosinophils in chronic eosinophilic pneumonia. Saita N; Yamanaka T; Kohrogi H; Matsumoto M; Suga M; Ando M; Hirashima M Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():64-6. PubMed ID: 9363929 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791 [TBL] [Abstract][Full Text] [Related]
11. Immunological analysis of organized pneumonia with eosinophilic pleural effusion. Hossain M; Okubo Y; Yamaguchi S; Horie S; Itoh S; Sugii S; Takatsu K; Oguchi T; Sekiguchi M Int Arch Allergy Immunol; 1996 Oct; 111(2):195-8. PubMed ID: 8859230 [TBL] [Abstract][Full Text] [Related]
12. Analysis of bronchoalveolar lavage cells in chronic eosinophilic pneumonia before and during corticosteroid therapy. Takahashi H; Arakawa Y; Oki K; Sugita H; Sakamoto S; Kawabata Y Int Arch Allergy Immunol; 1995; 108 Suppl 1():2-5. PubMed ID: 7549515 [TBL] [Abstract][Full Text] [Related]
13. Adhesion molecules on eosinophils in acute eosinophilic pneumonia. Okubo Y; Hossain M; Kai R; Sato E; Honda T; Sekiguchi M; Itoh S; Takatsu K Am J Respir Crit Care Med; 1995 Apr; 151(4):1259-62. PubMed ID: 7697263 [TBL] [Abstract][Full Text] [Related]